623585-74-0 Usage
General Description
Methyl 2,5-dichloroisonicotinate is a chemical compound with the molecular formula C7H5Cl2NO2. It is a derivative of isonicotinic acid and is known for its use in organic synthesis and pharmaceutical research. Methyl 2,5-dichloroisonicotinate is often used as an intermediate in the production of various pharmaceuticals, agrochemicals, and other organic compounds. It is characterized by its two chlorine atoms and a methyl ester group attached to the isonicotinate ring, giving it unique chemical and reactivity properties. Methyl 2,5-dichloroisonicotinate is often used in the development of new drugs and chemical compounds due to its versatile nature and potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 623585-74-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,3,5,8 and 5 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 623585-74:
(8*6)+(7*2)+(6*3)+(5*5)+(4*8)+(3*5)+(2*7)+(1*4)=170
170 % 10 = 0
So 623585-74-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H5Cl2NO2/c1-12-7(11)4-2-6(9)10-3-5(4)8/h2-3H,1H3
623585-74-0Relevant articles and documents
PLASMA KALLIKREIN INHIBITORS AND USES THEREOF
-
Paragraph 0911; 0912, (2021/03/19)
The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
PHTALAZINONE DERIVATIVES AS MPEGS -1 INHIBITORS
-
Page/Page column 55, (2013/06/05)
The present patent application is directed to bicyclic compounds of formula (I) or pharmaceutically acceptable salt thereof as mPGES-1 inhibitors. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (m PGES-1) enzyme and are theref
VIRAL POLYMERASE INHIBITORS
-
Page/Page column 83, (2009/01/20)
The present invention relates to viral polymerase inhibitors, in particular inhibitors of viral polymerases within the Flaviviridae family such as hepatitis C virus (HCV), processes for their preparation and their use in the treatment of infections.
